—Mkt Cap: —P/E: —
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procureme…
Industry Peers
Health Care Providers & ServicesKey Statistics
Company
Market Cap—
Enterprise Value10.13M $
Revenue (TTM)13.43M $
Gross Profit2.42M $
Net Income (TTM)-27.06K $
Revenue/Share0.5720 USD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees11
CountryUS
SectorHealthcare
IndustryHealth Care Providers & Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-11.03
EV/Revenue0.75
P/S1.48
P/B1.00
EPS (TTM)-0.07
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin11.89%
Oper. Margin-19.32%
EBITDA Margin-6.84%
Profit Margin-0.13%
ROE-0.54%
ROA-0.29%
Growth
Revenue Growth-31.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF569.21K $
CapEx (TTM)154.99K $
FCF Margin-48.44%
FCF Yield—
Net Debt1.04M $
Net Debt/EBITDA-1.13
Balance Sheet
Debt/Equity0.48
Current Ratio3.86
Quick Ratio1.69
Book Value/Sh0.4080 USD
Cash/Share0.0090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.35M
Float15.71M
Insiders17.34%
Institutions0.62%
Short Interest
Short Ratio0.4d
Short % Float6.35%
Short % Out.1.99%
Shares Short467.46K
Short (prev mo.)164.57K
Technical
SMA 500.4068 USD
SMA 2000.6636 USD
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)—
Avg Vol (10d)117.83K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—